Skip to main content

Drug Safety

      Bolhuis et al. PMR MODE study. MTX 25mg/week in recently diagnosed PMR. 52 weeks. 56 patients. Nada, zip, no effect. GC
      1 month 1 week ago

      Bolhuis et al. PMR MODE study. MTX 25mg/week in recently diagnosed PMR. 52 weeks. 56 patients. Nada, zip, no effect. GC free remission 67% vs 68%. No difference in any secondary outcome. @RheumNow #ACR24 Abstr#1697 #ACRbest https://t.co/Mb909u1zFT https://t.co/dShyBF4WST

      RA-ILD:
      💡Lifetime prevalence seems low but ~40% can have subclincal.
      💡Screen early in symptomatic pts.
      💡RA dise
      1 month 1 week ago
      RA-ILD: 💡Lifetime prevalence seems low but ~40% can have subclincal. 💡Screen early in symptomatic pts. 💡RA disease control decreases ILD progression and mortality. 💡RA-ILD UIP pattern seems to respond to immunosuppression. #ACR24 @RheumNow https://t.co/q3iACMeYVU
      When you stop 🛑 #TCZ #tocilizumab at
      6 months of #Rx in #PMR
      RELAPSES are V high

      DON’T stop #Toci in PMR too
      Earl
      1 month 1 week ago
      When you stop 🛑 #TCZ #tocilizumab at 6 months of #Rx in #PMR RELAPSES are V high DON’T stop #Toci in PMR too Early Rapid and frequent flares #ACR24 @RheumNow @ACRheum #1698 https://t.co/IX5EJOcIY5
      This will change my practice!
      #RCT #MMF + #MTX
      superior to
      #Cyclophosphamide then #Azathioprine

      In
      #Tayakasu’s #ar
      1 month 1 week ago
      This will change my practice! #RCT #MMF + #MTX superior to #Cyclophosphamide then #Azathioprine In #Tayakasu’s #arteritis N=150 RCT ~1g BID #mycophenolate + 15mg/wk #Methotrexate Vs #cyclo ➡️100mg #azathioprine All got #glucocorticoids #ACR24 @RheumNow @ACRheum #1696 https://t.co/OpRep1vsmx
      Safer and less relapses in
      #Takayasu’s #arteritis
      In
      #MTX + #MMF
      Vs
      #Cyclo ➡️ #azathioprine

      @RheumNow #ACRBes
      1 month 1 week ago
      Safer and less relapses in #Takayasu’s #arteritis In #MTX + #MMF Vs #Cyclo ➡️ #azathioprine @RheumNow #ACRBest @ACRheum abst#1696 WOW 😮 Amazing! https://t.co/y3BDjdAa6P
      Can we use MTX+MMF to treat active #TAK rather than CYC?

      ➡️MTX+MMF vs CYC/AZA over 52W

      MTX+MMF had:
      ⬆️Better e
      1 month 1 week ago
      Can we use MTX+MMF to treat active #TAK rather than CYC? ➡️MTX+MMF vs CYC/AZA over 52W MTX+MMF had: ⬆️Better efficacy in inducing & maintaining remission ❕Comparable safety to CYC/AZA ⏩This combination may prove preferable to using CYC Ab1696 #ACR24 @RheumNow https://t.co/S0A8YNk3qL
      #Methotrexate is a dud in #PMR for benefit above #glucocorticoids !

      #RCT MTX25mg/wk + Pred 15
      Mg/d tapered to 0 at 1 yr
      1 month 1 week ago
      #Methotrexate is a dud in #PMR for benefit above #glucocorticoids ! #RCT MTX25mg/wk + Pred 15 Mg/d tapered to 0 at 1 yr vs #Prednisone + placebo same taper NO BENEFIT from #MTX #1697 #ACR24 @ACRheum @RheumNow As FYI Poster at #EULAR observed #Leflunomide better than #MTX https://t.co/RepBmOKIsA
      Very neat simulated model of GC regimens in AAV pt on fixed RTX by @zach_wallace_md and co

      Over 5 years:
      - No differe
      1 month 1 week ago
      Very neat simulated model of GC regimens in AAV pt on fixed RTX by @zach_wallace_md and co Over 5 years: - No difference in relapse btwn standard GC vs. minimal GC + avacopan - Higher DMII rates in standard group Adds to trial + real world data @RheumNow #ACR24 Abst 1598
      Belimumab, anifrolumab and voclosporin exhibited an increase in claims from 2017-2022 for #SLE
      Belimumab ~ 600% increase
      1 month 1 week ago
      Belimumab, anifrolumab and voclosporin exhibited an increase in claims from 2017-2022 for #SLE Belimumab ~ 600% increase!! @RheumNow #ACR24 abst#1259 https://t.co/norl1xk2KF
      ×